Ignite Creation Date:
2024-07-17 @ 11:14 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466824
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-14
Brief Title:
Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Study Overview
Official Title:
Observational Study on the Outcome of Patients With Primary Immune Thrombocytopenia ITP Who Underwent Splenectomy After January 1st 2010
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Retrospective data collection on ITP patients who underwent splenectomy from 01012010 to 12312022 The expected enrollment period is 6 months The observation period of the enrolled patients is at least 1 year
Detailed Description:
Observational longitudinal retrospective study on ITP patients Patients with ITP who underwent splenectomy from 01012010 to 12312022 will be enrolled All useful data will be collected exclusively through consultation of outpatient medical records The expected enrollment period is 6 months The observation period of the enrolled patients is at least 1 year
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None